(Q39502524)

12 September 2017

title

Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79760

4 November 2022

1 reference

O. Ylikorkala

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79760

4 November 2022

A. Kauppila

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79760

4 November 2022

M. Siljander

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A79760

4 November 2022

language of work or name

English

0 references

publication date

1 August 1978

1 reference

12 September 2017

19 August 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=79760

full work available at URL

4 November 2022

https://api.elsevier.com/content/article/PII:S0140673678918640?httpAccept=text/xml

1 reference

10.1016/S0140-6736(78)91864-0

DOI

https://api.crossref.org/works/10.1016/S0140-6736(78)91864-0

https://api.elsevier.com/content/article/PII:S0140673678918640?httpAccept=text/plain

4 November 2022

1 reference

10.1016/S0140-6736(78)91864-0

DOI

https://api.crossref.org/works/10.1016/S0140-6736(78)91864-0

4 November 2022

1 reference

12 September 2017

volume

2

1 reference

12 September 2017

issue

8086

1 reference

12 September 2017

page(s)

393-395

1 reference

The Effectiveness of the Copper-T Intrauterine Device: A Collaborative Study in Five Countries

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Intrauterine contraception with the copper 7: evaluation after two years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Biologic mode of action of the Lippes loop in intrauterine contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Intrauterine device: possible role of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Levels of prostaglandins in the uterine endometrium during the ovine estrous cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Prostaglandin mediated luteolytic effect of an intrauterine device in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Release of prostaglandins by the I.U.C.D.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Prostaglandin mediated action of IUD's (II) F-prostaglandins (PGF) in the uterine horn of pregnant rats and hamsters with intrauterine devices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Prostaglandin-Mediated Action of Intrauterine Devices: F-prostaglandins in the Uterine Horns of Pregnant Rabbits with Unilateral Intrauterine Devices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Inhibition of prostaglandin biosynthesis by tolfenamic acid in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Mefenamic Acid in Dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Prostaglandins, indomethacin and dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

PROSTAGLANDINS IN ENDOMETRIUM AND MENSTRUAL FLUID FROM NORMAL AND DYSMENORRHOEIC SUBJECTS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

Cofactors in the biosynthesis of prostaglandins F1α and F2α

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991864-0

7 January 2021

10.1016/S0140-6736(78)91864-0

Identifiers

DOI

1 reference

12 September 2017

1 reference